Carpmaels & Ransford Ranks in Top Tier for IP Patent & Trade Mark Attorneys
20
Oct
2022
Six of the firm's partners have received individual recognition

Carpmaels & Ransford is delighted to announce that we have again been ranked in Band 1, UK-wide, for Intellectual Property: Patent & Trade Mark Attorneys, in the 2023 edition of Chambers & Partners. Our Managing Partner, Hugh Goodfellow, and Partner, Cameron Marshall, have been ranked in the top tier UK-wide for Intellectual Property Patent Attorneys.

Six partners from the firm received individual recognition, including Jennifer Antcliff who is newly recommended as “Up and Coming” for her coordination and litigation of patent disputes in the life sciences sector. Partners Camilla Balleny, David Wilson, and Ian Kirby were also ranked and recommended in their respective fields.

Comments from Chambers & Partners:

Carpmaels & Ransford is a powerful patent litigation practice built on the solid foundations of one of the country’s leading patent attorney firms. The team draws on deep wells of knowledge across all conceivable scientific disciplines but has particularly cut a dash in life sciences.

(The firm) has well-established IP practice, with expert patent and trade mark attorneys as well as solicitors acting for a range of clients in the life sciences sector. In addition to acting on patent prosecution and disputes, the team also offers support on the IP aspects of transactions between biotech and pharmaceuticals companies.

Comments from clients: 

“Carpmaels has a great team set-up with just the right depth and breadth and clear allocation of responsibility within the team. They provide excellent service and have a clear commercial awareness.”

“They have an excellent team accustomed to dealing with a diverse range of sophisticated matters covering all IP issues. They provide an excellent, proactive and responsive service.”

“Carpmaels & Ransford have excellent depth of high-level expertise in life sciences, and their ability to reach out to their patent team for advice and insights into IP and internationally for territory-specific insights was key.”

Six Partners received individual recognition in this year’s directory:

Hugh Goodfellow assists clients in the life sciences sector with all facets of patent prosecution and is sought after to coordinate multi-jurisdictional SPC filing programmes. He currently sits as the firm’s managing partner. According to clients he is “a tremendous EPO patent attorney who always responds in a timely manner despite also managing the firm’s affairs. He is very experienced and a delight to work with.”

Cameron Marshall is an expert in biochemical patent prosecution and frequently acts in oppositions before the UK and EU registries. He has a strong client base in biotech and pharmaceuticals. Clients comment that “Cameron Marshall is the best EU patent attorney I have ever worked with. He is very gifted and creative.”

David Wilson has a wealth of experience defending and bringing claims for corporations in patent infringement and revocation actions. He has particular expertise representing top pharmaceutical companies. Clients commented that he is “extremely knowledgeable, quick and practically-minded.”

Camilla Balleny leverages her scientific background to assist a broad range of life sciences companies with complex patent disputes. She often handles multi-jurisdictional cases. Sources note that Camilla “remains calm when handling hugely stressful cases and gives clients incisive advice. She is a real team player.”

Ian Kirby is noted for his success as a patent litigator acting for medical device and pharmaceutical manufacturers. He has also recently been instructed by clients in financial services and consumer goods. Clients comment that he is “an excellent patent litigator.”

Jennifer Antcliff has a strong patent litigation practice, and is regularly instructed to act by major clients in the life science space. Clients commented that Jennifer “is an upcoming star. She is incredibly hard-working and goes the extra mile for her clients.”